Introduction: Penile metastases are an extremely rare occurrence, and most primary malignancies are located in the urinary bladder, prostate, rectum, and rectosigmoid. Although very few cases of penile metastases have been reported, those of lung cancer as the primary tumor are very rare. Among the latter, squamous cell carcinomas constitute the majority, whereas adenocarcinomas are almost exceptions. To the best of our knowledge, only two cases have been reported.

Case Presentation: We report the case of a 59-year-old Greek man who presented with persistent cough and chest pain that had started one month prior to a medical appointment. A physical examination, complete laboratory work-up, computed tomography scanning (of the chest, brain, and abdomen), pelvic magnetic resonance imaging, penile ultrasonography, bone scanning, and histological analyses were conducted. Afterward, a lung adenocarcinoma metastatic to the bones, brain, adrenals, lymph nodes, and penis was diagnosed. The primary lesion was a mass of 4cm in diameter in the apical segment of the lower lobe of the right lung. The patient was treated with bone and brain radiotherapy and various cycles of first- and second-line chemotherapy, and partial response was achieved five months after the initial appointment.

Conclusions: Although these metastatic sites are well known to occur from a primary pulmonary malignancy, penile metastasis is extremely rare. Its identification requires prompt awareness by the physician despite the dismal prognosis. Furthermore, since the penis usually is omitted from the physical examination and lung cancer is the leading cause of cancer-related deaths, more penile metastases may be detected in the future, making early detection and appropriate management of great importance.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441777PMC
http://dx.doi.org/10.1186/1752-1947-6-252DOI Listing

Publication Analysis

Top Keywords

penile metastases
12
penile metastasis
8
extremely rare
8
lung cancer
8
physical examination
8
penile
6
pulmonary adenocarcinoma
4
adenocarcinoma presenting
4
presenting penile
4
metastasis case
4

Similar Publications

Article Synopsis
  • A 69-year-old Jamaican male with initially diagnosed gastric adenocarcinoma underwent standard treatment, including surgical resection and chemoradiation.
  • Two years later, he experienced dyspareunia and was found to have penile skin changes, leading to a diagnosis of metastatic gastric cancer.
  • After receiving chemotherapy and salvage radiotherapy, he was monitored for 15 months but eventually lost to follow-up and passed away.
View Article and Find Full Text PDF

Background: Inguinal lymph node dissection (ILND) is the standard of care for palpable, biopsy-proven lymph node metastases or high-risk groups for nonpalpable lymph nodes in the treatment of penile cancer. ILND is associated with a significant incidence of complications and adverse events, specifically wound complications. Few studies have identified risk factors related to postoperative ILND complications.

View Article and Find Full Text PDF

Late metastasis of rectal adenocarcinoma to the penis.

BMJ Case Rep

November 2024

Urology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Rectal cancer metastasising to the penis is an exceptionally rare clinical entity, with less than 80 reported cases. Metastasis to the penis is typically identified in conjunction with widespread metastatic disease and as such is usually associated with a very poor prognosis. We report a case of a man who presented with a metastatic deposit in his penis 15 years after the initial diagnosis of rectal cancer.

View Article and Find Full Text PDF

The penis is a relatively uncommon organ for metastases. Secondary lesions often originate from the bladder, prostate, or rectosigmoid cancers. Only a few cases have described penile lesions secondary to lung cancers, mostly as a later complication.

View Article and Find Full Text PDF
Article Synopsis
  • Extramammary Paget disease (EMPD) is a rare type of skin cancer that mainly affects areas with apocrine glands like the vulva, scrotum, and penis, and often has a poor prognosis, especially with distant metastases.
  • Patients with localized EMPD generally have a good 5-year survival rate between 60%-92%, while those with metastases only have about a 10% survival rate.
  • A case report highlights a 57-year-old man with metastatic EMPD who responded well to a combination of an immune checkpoint inhibitor and chemotherapy, suggesting this approach may improve outcomes for others with similar advanced disease.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!